Impression Wuyi (02695): Hong Kong public offering received 3397.48 times oversubscription, with the offer price of HK$3.6 per share.
Impression Wuyi (02695) announced the distribution results. The company conducted a global offering of approximately 36.1 million H shares, with 10% offered in Hong Kong and 90% offered internationally. The offering price per share was HK$3.6, raising a net amount of 104 million Hong Kong dollars. Each board lot consists of 1,000 H shares, and trading of the shares on the Stock Exchange of Hong Kong is expected to begin at 9:00 am on December 22, 2025.
Impression Wuyi (02695) announced the distribution results, with approximately 36.1 million H shares sold globally. 10% of the shares were publicly sold in Hong Kong, while 90% were sold internationally. The selling price per share was HK$3.6, raising a net total of HK$104 million from the global distribution. Each lot consisted of 1000 H shares, and trading is expected to commence on the Hong Kong Stock Exchange on December 22, 2025, at 9:00 am.
The public sale in Hong Kong was oversubscribed by 3397.48 times, while the international sale was oversubscribed by 1.91 times.
Related Articles
CHINA LESSO (02128) and Guangdong Liansu Electric have signed a parts supply agreement.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-2906 Injection Obtains Drug Clinical Trial Approval Letter.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-9539 injection, HRS-3738 tablets received the approval notice for drug clinical trials.
CHINA LESSO (02128) and Guangdong Liansu Electric have signed a parts supply agreement.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-2906 Injection Obtains Drug Clinical Trial Approval Letter.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-9539 injection, HRS-3738 tablets received the approval notice for drug clinical trials.
